The title compound, C(29)H(17)FN(4)O(2), may be used as a new precursor for obtaining bioactive mol-ecules. There are two crystallographically independent mol-ecules in the asymmetric unit. The phenyl ring, 4-fluoro-phenyl ring and 2-naphth-yloxy ring are twisted with respect to the pyrrolopyrimidine ring by 52.30 (11)/49.05 (11), 80.94 (10)/88.36 (10) and 60.58 (7)/83.76 (7)°, respectively. The crystal packing is stabilized by weak C-H⋯N hydrogen bonds.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970989 | PMC |
| http://dx.doi.org/10.1107/S1600536809039531 | DOI Listing |
Publication Analysis
Top Keywords
title compound
4
compound c29h17fn4o2
4
c29h17fn4o2 precursor
4
precursor obtaining
4
obtaining bioactive
4
bioactive mol-ecules
4
mol-ecules crystallographically
4
crystallographically independent
4
independent mol-ecules
4
mol-ecules asymmetric
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!